By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Akorn, Inc. 

1925 West Field Court

Lake Forest  Illinois  60045  U.S.A.
Phone: 847-279-6100 Fax: 847-236-3823



Drug Discovery

Company News
Akorn, Inc. (AKN) Announces Second Quarter 2016 Earnings Release And Conference Call Information 7/21/2016 7:33:41 AM
Akorn, Inc. (AKN) Provides Preliminary Unaudited Full Year 2015 Financial Results And Issues 2016 Financial Guidance 3/22/2016 8:09:04 AM
Akorn, Inc. (AKN) Appoints Greg Lawless As Chief Human Resources Officer 1/21/2016 7:44:02 AM
Akorn, Inc. (AKN) Launches Buprenorphine/Naloxone Sublingual Tablets And Tobramycin Injection 1/19/2016 7:43:33 AM
Akorn, Inc. (AKN) Receives Additional Delinquency Notice From Nasdaq 11/16/2015 7:56:50 AM
Akorn, Inc. (AKN) Provides Update On Alternative Fulfillment Systems 10/22/2015 8:11:47 AM
Akorn, Inc. (AKN) Appoints Duane A. Portwood As Chief Financial Officer 10/14/2015 10:34:01 AM
Akorn, Inc. (AKN) Launches Myorisan(TM) 30 mg Capsules 9/28/2015 6:34:07 AM
Akorn, Inc. (AKN) Launches Doxercalciferol Injection 9/21/2015 9:04:17 AM
Akorn, Inc. (AKN) Launches Two Additional Promethazine Syrup Formulations 9/17/2015 6:13:25 AM